Compounds / Other / Prostamax

Prostamax

Prostamax (KEDP — Synthetic Tetrapeptide Prostate Bioregulator)
OtherLimited ResearchFDA: Not approved

Overview

Preclinical: chronic aseptic prostatitis model — reduced inflammation markers. Anti-sclerotic prostate effects. Khavinson Institute program. Limited Western peer-reviewed data.

Mechanism of Action

Khavinson tetrapeptide Lys-Glu-Asp-Pro (KEDP). Prostate tissue specificity. Enhances proliferative and metabolic activity in prostate epithelial cells and fibroblasts. Anti-sclerotic: prevents sclerotic and atrophic processes in chronic prostatitis. Reduces tissue swelling, vascular hyperemia, and lymphoid infiltration.

Molecular Profile

Molecular weight
487.5 Da
Type
Tetrapeptide
Length
4 amino acids
Lys-Glu-Asp-Pro (KEDP)

Key Research Findings

KEDP tetrapeptide; prostate specificity; anti-sclerotic; fibroblast activation; chronic prostatitis preclinical data; Khavinson bioregulator.

Published Research

Vrach Delo (1991)
Gorpinchenko II et al. (Khavinson VK). Prostatilen polypeptide treatment of prostatitis (precursor cytomedin research)
View source

Related Other Compounds

PT-141Melanotan IMelanotan IIPNC-27CystagenDermorphin
Clinical Guidance

Research data is not a treatment plan. If you are considering Prostamax, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.
Running Prostamax? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator  ·  Full deep dive  ·  Peptide fundamentals